Novosis Putty Sets the Stage for U.S. Market Success with Promising Clinical Results
- Written by PR Newswire
![]() |
SEOUL, South Korea, May 14, 2024 /PRNewswire/ -- CGBio, a leading medical device company, announced a significant clinical results demonstrating a 100% interbody fusion success rate at 52 weeks for its innovative bone substitutes, "Novosis" and "Excelos Inject," which have been published in the 'Journal of Clinical Medicine'. These results not...
Read more: Novosis Putty Sets the Stage for U.S. Market Success with Promising Clinical Results















